Cardiovascular Risk Reduction in Atrial Fibrillation Trial

NCT04347330 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

1675

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Hypertension

Interventions

DRUG: Intensive BP Control
DRUG: Standard BP Control

Sponsor

Beijing Anzhen Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]